Singapore - English - HSA (Health Sciences Authority)

elekta pte. ltd. - radiology / imaging - is a software that is intended to create treatment plans for any cancer patient for whom external beam radiation therapy has been prescribed.

Singapore - English - HSA (Health Sciences Authority)

elekta pte. ltd. - radiology / imaging - it is intended to be used for immobilisation, positioning and re-positioning during stereotactic radiotherapy in all parts of the brain and head in a linac environment.further it is used to immobilize and position the head during image acquisition to support treatment planning. under certain circumstances(e.g. when the patient will not tolerate an invasive frame) it may also be used for stereotactic radiosurgery(srs) in a linear accelerator environment.

Singapore - English - HSA (Health Sciences Authority)

elekta pte. ltd. - radiology / imaging - is a software is intended to facilitate the delivery of defined radiotherapy treatment plans. sequencer verifies the settings on a radiotherapy treatment machine prior to treatment and records the actual parameters after treatment. sequencer can be used whenever radiotherapy treatment is prescribed.

Singapore - English - HSA (Health Sciences Authority)

elekta pte. ltd. - radiology / imaging - is a software intended to provide health care facility personnel with an efficient and effective means to utilize patient images during the course of therapy or treatment. viewstation allows users to import, view, annotate, manipulate, enhance, manage, and archive patient images.

Malta - English - Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - levofloxacin - film-coated tablet - levofloxacin 500 mg - antibacterials for systemic use

Malta - English - Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - perindopril tert, butylamine salt, indapamide - tablet - perindopril tert-butylamine salt 4 mg indapamide 1.25 mg - agents acting on the renin-angiotensin system

United States - English - NLM (National Library of Medicine)

lek pharmaceuticals - bromocriptine mesylate (unii: ffp983j3od) (bromocriptine - unii:3a64e3g5zo) - tablet - 2.5 mg - bromocriptine mesylate tablets are indicated for the treatment of dysfunctions associated with hyperprolactinemia including amenorrhea with or without galactorrhea, infertility or hypogonadism. bromocriptine mesylate treatment is indicated in patients with prolactin-secreting adenomas, which may be the basic underlying endocrinopathy contributing to the above clinical presentations. reduction in tumor size has been demonstrated in both male and female patients with macroadenomas. in cases where adenectomy is elected, a course of bromocriptine mesylate therapy may be used to reduce the tumor mass prior to surgery. acromegaly bromocriptine mesylate tablets are indicated in the treatment of acromegaly. bromocriptine mesylate therapy, alone or as adjunctive therapy with pituitary irradiation or surgery, reduces serum growth hormone by 50% or more in approximately one-half of patients treated, although not usually to normal levels. since the effects of external pituitary radiation may not become maximal for

United States - English - NLM (National Library of Medicine)

lek pharmaceuticals - lisinopril (unii: e7199s1ywr) (lisinopril - unii:e7199s1ywr) - tablet - 2.5 mg -  lisinopril tablets are indicated for the treatment of hypertension. they may be used alone as initial therapy or concomitantly with other classes of antihypertensive agents. lisinopril tablets are indicated as adjunctive therapy in the management of heart failure in patients who are not responding adequately to diuretics and digitalis.  lisinopril tablets are indicated for the treatment of hemodynamically stable patients within 24 hours of acute myocardial infarction, to improve survival. patients should receive, as appropriate, the standard recommended treatments such as thrombolytics, aspirin, and beta-blockers. in using lisinopril tablets, consideration should be given to the fact that another angiotensin converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen vascular disease, and that available data are insufficient to show that lisinopril tablets do not have a similar risk. (see warnings.) in considering the use of lisinopril tablet

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

lek pharmaceuticals d.d. - pregabalin - capsules hard - 150mg

Malta - English - Medicines Authority

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - celecoxib - hard capsule - celecoxib 100 mg - antiinflammatory and antirheumatic products